Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017, Article ID 7953486, 13 pages
https://doi.org/10.1155/2017/7953486
Review Article

The Light and Shadow of Senescence and Inflammation in Cardiovascular Pathology and Regenerative Medicine

1Cardiovascular Regenerative Medicine Group, Department of Cardiac, Thoracic and Vascular Surgery, University of Padua and Venetian Institute of Molecular Medicine, Padua, Italy
2Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy
3IRCCS Neuromed, Pozzilli, Italy

Correspondence should be addressed to Laura Iop; ti.dpinu@poi.arual

Received 20 July 2017; Accepted 12 September 2017; Published 8 October 2017

Academic Editor: Carmela R. Balistreri

Copyright © 2017 Laura Iop et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. R. Cowie, “The global burden of heart failure,” http://www.escardio.org/static_file/Escardio/Web/Congresses/Slides/Heart%20failure%202015/1183%20-%20The%20global%20burden%20of%20heart%20failure.%20-%20Martin%20COWIE%20(London,%20United%20Kingdom).pdf.
  2. L. Hayflick and P. S. Moorhead, “The serial cultivation of human diploid cell strains,” Experimental Cell Research, vol. 25, pp. 585–621, 1961. View at Publisher · View at Google Scholar
  3. D. Munoz-Espin and M. Serrano, “Cellular senescence: from physiology to pathology,” Nature Reviews Molecular Cell Biology, vol. 15, pp. 482–496, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Munoz-Espin, M. Canamero, A. Maraver et al., “Programmed cell senescence during mammalian embryonic development,” Cell, vol. 155, pp. 1104–1118, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Storer, A. Mas, A. Robert-Moreno et al., “Senescence is a developmental mechanism that contributes to embryonic growth and patterning,” Cell, vol. 155, pp. 1119–1130, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. A. P. Beltrami, D. Cesselli, and C. A. Beltrami, “At the stem of youth and health,” Pharmacology and Therapeutics, vol. 129, pp. 3–20, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Serrano and M. A. Blasco, “Putting the stress on senescence,” Current Opinion in Cell Biology, vol. 13, pp. 748–753, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. T. von Zglinicki, “Telomeres and replicative senescence: is it only length that counts?” Cancer Letters, vol. 168, pp. 111–116, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. V. G. Gorgoulis and T. D. Halazonetis, “Oncogene-induced senescence: the bright and dark side of the response,” Current Opinion in Cell Biology, vol. 22, pp. 816–827, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. J.-P. Coppé, C. K. Patil, F. Rodier et al., “Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor,” PLoS Biology, vol. 6, article e301, 2008. View at Publisher · View at Google Scholar
  11. J. C. Acosta, A. Banito, T. Wuestefeld et al., “A complex secretory program orchestrated by the inflammasome controls paracrine senescence,” Nature Cell Biology, vol. 15, pp. 978–990, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. M. F. O’Rourke, M. E. Safar, and V. Dzau, “The cardiovascular continuum extended: aging effects on the aorta and microvasculature,” Vascular Medicine, vol. 15, pp. 461–468, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Minamino and I. Komuro, “Role of telomere in endothelial dysfunction in atherosclerosis,” Current Opinion in Lipidology, vol. 13, pp. 537–543, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Minamino, H. Miyauchi, T. Yoshida, Y. Ishida, H. Yoshida, and I. Komuro, “Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction,” Circulation, vol. 105, pp. 1541–1544, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. C. F. Moyer, D. Sajuthi, H. Tulli, and J. K. Williams, “Synthesis of IL-1 alpha and IL-1 beta by arterial cells in atherosclerosis,” The American Journal of Pathology, vol. 138, pp. 951–960, 1991. View at Google Scholar
  16. S. E. Gardner, M. Humphry, M. R. Bennett, and M. C. H. Clarke, “Senescent vascular smooth muscle cells drive inflammation through an interleukin-1α- dependent senescence-associated secretory phenotype,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 35, pp. 1963–1974, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Mistriotis and S. T. Andreadis, “Vascular aging: molecular mechanisms and potential treatments for vascular rejuvenation,” Ageing Research Reviews, vol. 37, pp. 94–116, 2017. View at Publisher · View at Google Scholar
  18. R. Stanzione, S. Sciarretta, S. Marchitti et al., “C2238/αANP modulates apolipoprotein E through Egr-1/miR199a in vascular smooth muscle cells in vitro,” Cell Death and Disease, vol. 6, article e2033, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Laina, K. Stellos, and K. Stamatelopoulos, “Vascular ageing: underlying mechanisms and clinical implications,” Experimental Gerontology, 2017. View at Publisher · View at Google Scholar
  20. F. Paneni, C. Diaz Canestro, P. Libby, T. F. Luescher, and G. G. Camici, “The aging cardiovascular system: understanding it at the cellular and clinical levels,” Journal of the American College of Cardiology, vol. 69, pp. 1952–1967, 2017. View at Publisher · View at Google Scholar
  21. T. Minamino, H. Miyauchi, T. Yoshida, K. Tateno, T. Kunieda, and I. Komuro, “Vascular cell senescence and vascular aging,” Journal of Molecular and Cellular Cardiology, vol. 36, pp. 175–183, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. D. G. A. Burton, H. Matsubara, and K. Ikeda, “Pathophysiology of vascular calcification: pivotal role of cellular senescence in vascular smooth muscle cells,” Experimental Gerontology, vol. 45, pp. 819–824, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Nanni, G. Melandri, R. Hanemaaijer et al., “Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms,” Translational Research, vol. 149, pp. 137–144, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Nakajima, M. Hashimoto, F. Wang et al., “Aging decreases the production of PGI2 in rat aortic endothelial cells,” Experimental Gerontology, vol. 32, pp. 685–693, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Carnevale, L. Loffredo, C. Nocella et al., “Epicatechin and catechin modulate endothelial activation induced by platelets of patients with peripheral artery disease,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 691015, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Carrizzo, C. Vecchione, A. Damato et al., “Rac1 pharmacological inhibition rescues human endothelial dysfunction,” Journal of the American Heart Association, vol. 6, article e004746, 2017. View at Publisher · View at Google Scholar
  27. W. R. Jeck, A. P. Siebold, and N. E. Sharpless, “Review: a meta-analysis of GWAS and age-associated diseases,” Aging Cell, vol. 11, pp. 727–731, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. J. J. Fuster, P. Molina-Sanchez, D. Jovani, A. Vinué, M. Serrano, and V. Andrés, “Increased gene dosage of the Ink4/Arf locus does not attenuate atherosclerosis development in hypercholesterolaemic mice,” Atherosclerosis, vol. 221, pp. 98–105, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Golledge and H. Kuivaniemi, “Genetics of abdominal aortic aneurysm,” Current Opinion in Cardiology, vol. 28, pp. 290–296, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. X. Zhou, F. Perez, K. Han, and D. A. Jurivich, “Clonal senescence alters endothelial ICAM-1 function,” Mechanisms of Ageing and Development, vol. 127, pp. 779–785, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Comi, R. Chiaramonte, and J. A. M. Maier, “Senescence-dependent regulation of type 1 plasminogen activator inhibitor in human vascular endothelial cells,” Experimental Cell Research, vol. 219, pp. 304–308, 1995. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Garfinkel, S. Brown, J. H. Wessendorf, and T. Maciag, “Post-transcriptional regulation of interleukin 1 alpha in various strains of young and senescent human umbilical vein endothelial cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, pp. 1559–1563, 1994. View at Publisher · View at Google Scholar
  33. E. De Falco, R. Carnevale, F. Pagano et al., “Role of NOX2 in mediating doxorubicin-induced senescence in human endothelial progenitor cells,” Mechanisms of Ageing and Development, vol. 159, pp. 37–43, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Alique, M. P. Ruíz-Torres, G. Bodega et al., “Microvesicles from the plasma of elderly subjects and from senescent endothelial cells promote vascular calcification,” Aging, vol. 9, pp. 778–789, 2017. View at Publisher · View at Google Scholar
  35. A. Leri, S. Franco, A. Zacheo et al., “Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation,” The EMBO Journal, vol. 22, pp. 131–139, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Benetos, J. P. Gardner, M. Zureik et al., “Short telomeres are associated with increased carotid atherosclerosis in hypertensive subjects,” Hypertension, vol. 43, pp. 182–185, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Willeit, J. Willeit, A. Brandstatter et al., “Cellular aging reflected by leukocyte telomere length predicts advanced atherosclerosis and cardiovascular disease risk,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, pp. 1649–1656, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. P. C. Haycock, E. E. Heydon, S. Kaptoge, A. S. Butterworth, A. Thompson, and P. Willeit, “Leucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis,” BMJ, vol. 349, article g4227, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Ikeda, S. Sciarretta, N. Nagarajan et al., “New insights into the role of mitochondrial dynamics and autophagy during oxidative stress and aging in the heart,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 210934, 13 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Y. Gebreab, Z. G. Manna, R. J. Khan, P. Riestra, R. Xu, and S. K. Davis, “Less than ideal cardiovascular health is associated with shorter leukocyte telomere length: the National Health and Nutrition Examination Surveys, 1999–2002,” Journal of the American Heart Association, vol. 6, article e004105, 2017. View at Publisher · View at Google Scholar
  41. M. Taneike, O. Yamaguchi, A. Nakai et al., “Inhibition of autophagy in the heart induces age-related cardiomyopathy,” Autophagy, vol. 6, pp. 600–606, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. D. A. Kubli, X. Zhang, Y. Lee et al., “Parkin protein deficiency exacerbates cardiac injury and reduces survival following myocardial infarction,” The Journal of Biological Chemistry, vol. 288, pp. 915–926, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Eisenberg, M. Abdellatif, S. Schroeder et al., “Cardioprotection and lifespan extension by the natural polyamine spermidine,” Nature Medicine, vol. 22, pp. 1428–1438, 2016. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Shirakabe, Y. Ikeda, S. Sciarretta, D. K. Zablocki, and J. Sadoshima, “Aging and autophagy in the heart,” Circulation Research, vol. 118, pp. 1563–1576, 2016. View at Publisher · View at Google Scholar · View at Scopus
  45. S. K. Gupta, A. Foinquinos, S. Thum et al., “Preclinical development of a MicroRNA-based therapy for elderly patients with myocardial infarction,” Journal of the American College of Cardiology, vol. 68, pp. 1557–1571, 2016. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Sciarretta, E. De Falco, G. Frati, and J. Sadoshima, “How to be young at heart? miR-22 as a potential therapeutic target to boost autophagy and protect the old myocardium,” Annals of Translational Medicine, vol. 5, pp. 52–52, 2017. View at Publisher · View at Google Scholar
  47. A. Herraiz-Martinez, J. Alvarez-Garcia, A. Llach et al., “Ageing is associated with deterioration of calcium homeostasis in isolated human right atrial myocytes,” Cardiovascular Research, vol. 106, pp. 76–86, 2015. View at Publisher · View at Google Scholar · View at Scopus
  48. H. A. Feridooni, K. M. Dibb, and S. E. Howlett, “How cardiomyocyte excitation, calcium release and contraction become altered with age,” Journal of Molecular and Cellular Cardiology, vol. 83, pp. 62–72, 2015. View at Publisher · View at Google Scholar · View at Scopus
  49. F. H. H. Leenen, E. Coletta, A. Fourney, and R. White, “Aging and cardiac responses to epinephrine in humans: role of neuronal uptake,” American Journal of Physiology. Heart and Circulatory Physiology, vol. 288, pp. H2498–H2503, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. K. Leineweber, T. Wangemann, C. Giessler et al., “Age-dependent changes of cardiac neuronal noradrenaline reuptake transporter (uptake1) in the human heart,” Journal of the American College of Cardiology, vol. 40, p. 1459, 2002. View at Google Scholar
  51. K. Ocorr, A. Zambon, Y. Nudell et al., “Age-dependent electrical and morphological remodeling of the Drosophila heart caused by hERG/seizure mutations,” PLoS Genetics, vol. 13, article e1006786, 2017. View at Publisher · View at Google Scholar
  52. S. He, C. He, H. Yuan, S. Xiong, Z. Xiao, and L. Chen, “The SIRT 3 expression profile is associated with pathological and clinical outcomes in human breast cancer patients,” Cellular Physiology and Biochemistry, vol. 34, pp. 2061–2069, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. H. Dou, A. Feher, A. C. Davila et al., “Role of adipose tissue endothelial ADAM17 in age-related coronary microvascular dysfunction,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 37, pp. 1180–1193, 2017. View at Publisher · View at Google Scholar
  54. X. Wang, Z. Guo, Z. Ding et al., “Endothelin-1 upregulation mediates aging-related cardiac fibrosis,” Journal of Molecular and Cellular Cardiology, vol. 80, pp. 101–109, 2015. View at Publisher · View at Google Scholar · View at Scopus
  55. F. Zhu, Y. Li, J. Zhang et al., “Senescent cardiac fibroblast is critical for cardiac fibrosis after myocardial infarction,” PLoS One, vol. 8, article e74535, 2013. View at Publisher · View at Google Scholar
  56. K. Selthofer-Relatic, M. Mihalj, A. Kibel et al., “Coronary microcirculatory dysfunction in human cardiomyopathies,” Cardiology in Review, vol. 25, pp. 165–178, 2017. View at Publisher · View at Google Scholar
  57. C. Vlachopoulos, P. Xaplanteris, V. Aboyans et al., “The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation,” Atherosclerosis, vol. 241, pp. 507–532, 2015. View at Publisher · View at Google Scholar · View at Scopus
  58. M. K. Halushka, A. Angelini, G. Bartoloni et al., “Consensus statement on surgical pathology of the aorta from the Society for Cardiovascular Pathology and the Association For European Cardiovascular Pathology: II. Noninflammatory degenerative diseases — nomenclature and diagnostic criteria,” Cardiovascular Pathology, vol. 25, pp. 247–257, 2016. View at Publisher · View at Google Scholar · View at Scopus
  59. C. Y. Ho and C. M. Shanahan, “Medial arterial calcification: an overlooked player in peripheral arterial disease,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 36, pp. 1475–1482, 2016. View at Publisher · View at Google Scholar · View at Scopus
  60. C. R. Balistreri, G. Ruvolo, D. Lio, and R. Madonna, “Toll-like receptor-4 signaling pathway in aorta aging and diseases: “ its double nature”,” Journal of Molecular and Cellular Cardiology, vol. 110, pp. 38–53, 2017. View at Publisher · View at Google Scholar
  61. H. W. Kim and B. K. Stansfield, “Genetic and epigenetic regulation of aortic aneurysms,” BioMed Research International, vol. 2017, Article ID 7268521, 12 pages, 2017. View at Publisher · View at Google Scholar
  62. D. W. Wray, M. Amann, and R. S. Richardson, “Peripheral vascular function, oxygen delivery and utilization: the impact of oxidative stress in aging and heart failure with reduced ejection fraction,” Heart Failure Reviews, vol. 22, pp. 149–166, 2017. View at Publisher · View at Google Scholar · View at Scopus
  63. A. Moorman, S. Webb, N. A. Brown, W. Lamers, and R. H. Anderson, “Development of the heart: (1) formation of the cardiac chambers and arterial trunks,” Heart, vol. 89, pp. 806–814, 2003. View at Publisher · View at Google Scholar
  64. M. Buckingham, S. Meilhac, and S. Zaffran, “Building the mammalian heart from two sources of myocardial cells,” Nature Reviews Genetics, vol. 6, pp. 826–837, 2005. View at Publisher · View at Google Scholar · View at Scopus
  65. C.-L. Cai, X. Liang, Y. Shi et al., “Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart,” Developmental Cell, vol. 5, pp. 877–889, 2003. View at Publisher · View at Google Scholar · View at Scopus
  66. E. Messina, L. De Angelis, G. Frati et al., “Isolation and expansion of adult cardiac stem cells from human and murine heart,” Circulation Research, vol. 95, pp. 911–921, 2004. View at Publisher · View at Google Scholar · View at Scopus
  67. L. Barile, I. Chimenti, R. Gaetani et al., “Cardiac stem cells: isolation, expansion and experimental use for myocardial regeneration,” Nature Clinical Practice Cardiovascular Medicine, vol. 4, pp. S9–S14, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. Y. Zhang, T.-S. Li, S.-T. Lee et al., “Dedifferentiation and proliferation of mammalian cardiomyocytes,” PLoS One, vol. 5, article e12559, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. R. Gaetani, G. Rizzitelli, I. Chimenti et al., “Cardiospheres and tissue engineering for myocardial regeneration: potential for clinical application,” Journal of Cellular and Molecular Medicine, vol. 14, pp. 1071–1077, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. K. E. Hatzistergos and J. M. Hare, “Murine models demonstrate distinct vasculogenic and cardiomyogenic cKit + lineages in the heart,” Circulation Research, vol. 118, pp. 382–387, 2016. View at Publisher · View at Google Scholar · View at Scopus
  71. N. Smart, S. Bollini, K. N. Dubé et al., “De novo cardiomyocytes from within the activated adult heart after injury,” Nature, vol. 474, pp. 640–644, 2011. View at Publisher · View at Google Scholar · View at Scopus
  72. Y. Tomita, K. Matsumura, Y. Wakamatsu et al., “Cardiac neural crest cells contribute to the dormant multipotent stem cell in the mammalian heart,” The Journal of Cell Biology, vol. 170, pp. 1135–1146, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. D. H. Walter and S. Dimmeler, “Endothelial progenitor cells: regulation and contribution to adult neovascularization,” Herz, vol. 27, pp. 579–588, 2002. View at Publisher · View at Google Scholar · View at Scopus
  74. K. B. Pasumarthi and L. J. Field, “Cardiomyocyte enrichment in differentiating ES cell cultures: strategies and applications,” Embryonic Stem Cells, vol. 185, pp. 157–168, 2002. View at Google Scholar
  75. M. J. van Amerongen and F. B. Engel, “Features of cardiomyocyte proliferation and its potential for cardiac regeneration,” Journal of Cellular and Molecular Medicine, vol. 12, pp. 2233–2244, 2008. View at Publisher · View at Google Scholar · View at Scopus
  76. P. Ahuja, E. Perriard, J.-C. Perriard, and E. Ehler, “Sequential myofibrillar breakdown accompanies mitotic division of mammalian cardiomyocytes,” Journal of Cell Science, vol. 117, pp. 3295–3306, 2004. View at Publisher · View at Google Scholar · View at Scopus
  77. S. Ausoni and S. Sartore, “From fish to amphibians to mammals: in search of novel strategies to optimize cardiac regeneration,” The Journal of Cell Biology, vol. 184, pp. 357–364, 2009. View at Publisher · View at Google Scholar · View at Scopus
  78. G. K. Zupanc and D. L. Stocum, “Regeneration science needs to broaden its focus to understand why some organisms can regenerate and others not,” Regenerative Medicine, vol. 10, pp. 801–803, 2015. View at Publisher · View at Google Scholar · View at Scopus
  79. T. A. Baudino, W. Carver, W. Giles, and T. K. Borg, “Cardiac fibroblasts: friend or foe?” American Journal of Physiology: Heart and Circulatory Physiology, vol. 291, pp. H1015–H1026, 2006. View at Publisher · View at Google Scholar · View at Scopus
  80. D. Cesselli, A. P. Beltrami, F. D’Aurizio et al., “Effects of age and heart failure on human cardiac stem cell function,” The American Journal of Pathology, vol. 179, pp. 349–366, 2011. View at Publisher · View at Google Scholar · View at Scopus
  81. T. Nakamura, T. Hosoyama, J. Murakami et al., “Age-related increase in Wnt inhibitor causes a senescence-like phenotype in human cardiac stem cells,” Biochemical and Biophysical Research Communications, vol. 487, pp. 653–659, 2017. View at Publisher · View at Google Scholar
  82. E. Piegari, A. Angelis, D. Cappetta et al., “Doxorubicin induces senescence and impairs function of human cardiac progenitor cells,” Basic Research in Cardiology, vol. 108, p. 334, 2013. View at Publisher · View at Google Scholar · View at Scopus
  83. C. Chimenti, J. Kajstura, D. Torella et al., “Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure,” Circulation Research, vol. 93, pp. 604–613, 2003. View at Publisher · View at Google Scholar · View at Scopus
  84. B. Nadal-Ginard, J. Kajstura, A. Leri, and P. Anversa, “Myocyte death, growth, and regeneration in cardiac hypertrophy and failure,” Circulation Research, vol. 92, pp. 139–150, 2003. View at Publisher · View at Google Scholar · View at Scopus
  85. B. G. Galvez, D. Covarello, R. Tolorenzi et al., “Human cardiac mesoangioblasts isolated from hypertrophic cardiomyopathies are greatly reduced in proliferation and differentiation potency,” Cardiovascular Research, vol. 83, pp. 707–716, 2009. View at Publisher · View at Google Scholar · View at Scopus
  86. Q. Wu, J. Zhan, S. Pu, L. Qin, Y. Li, and Z. Zhou, “Influence of aging on the activity of mice Sca-1+CD31 cardiac stem cells,” Oncotarget, vol. 8, pp. 29–41, 2016. View at Publisher · View at Google Scholar
  87. F. Angelini, F. Pagano, A. Bordin et al., “The impact of environmental factors in influencing epigenetics related to oxidative states in the cardiovascular system,” Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 2712751, 18 pages, 2017. View at Publisher · View at Google Scholar
  88. B.-E. Strauer and G. Steinhoff, “10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart,” Journal of the American College of Cardiology, vol. 58, pp. 1095–1104, 2011. View at Publisher · View at Google Scholar · View at Scopus
  89. J. Zhu and S. G. Emerson, “Hematopoietic cytokines, transcription factors and lineage commitment,” Oncogene, vol. 21, pp. 3295–3313, 2002. View at Publisher · View at Google Scholar · View at Scopus
  90. M. C. Simon, “Mitochondrial reactive oxygen species are required for hypoxic HIFα stabilization,” Advances in Experimental Medicine and Biology, vol. 588, pp. 165–170, 2006. View at Publisher · View at Google Scholar · View at Scopus
  91. P. Eliasson and J.-I. Jonsson, “The hematopoietic stem cell niche: low in oxygen but a nice place to be,” Journal of Cellular Physiology, vol. 222, pp. 17–22, 2010. View at Publisher · View at Google Scholar · View at Scopus
  92. E. J. Kushner, O. J. MacEneaney, B. R. Weil, J. J. Greiner, B. L. Stauffer, and C. A. DeSouza, “Aging is associated with a proapoptotic endothelial progenitor cell phenotype,” Journal of Vascular Research, vol. 48, pp. 408–414, 2011. View at Publisher · View at Google Scholar · View at Scopus
  93. Y.-G. Yao, S. Kajigaya, L. Samsel, J. P. McCoy, G. Torelli, and N. S. Young, “Apparent mtDNA sequence heterogeneity in single human blood CD34+ cells is markedly affected by storage and transport,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 751–752, pp. 36–41, 2013. View at Publisher · View at Google Scholar · View at Scopus
  94. I. Beerman, W. J. Maloney, I. L. Weissmann, and D. J. Rossi, “Stem cells and the aging hematopoietic system,” Current Opinion in Immunology, vol. 22, pp. 500–506, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. U. M. Becher, C. Endtmann, V. Tiyerili, G. Nickenig, and N. Werner, “Endothelial damage and regeneration: the role of the renin-angiotensin-aldosterone system,” Current Hypertension Reports, vol. 13, pp. 86–92, 2011. View at Publisher · View at Google Scholar · View at Scopus
  96. F. Paneni, S. Costantino, N. Kränkel, F. Cosentino, and T. F. Lüscher, “Reprogramming ageing and longevity genes restores paracrine angiogenic properties of early outgrowth cells,” European Heart Journal, vol. 37, pp. 1733–1737, 2016. View at Publisher · View at Google Scholar · View at Scopus
  97. E. De Falco, A. Bordin, E. Scaccia et al., “Histone acetylation favours the cardiovascular commitment of adipose tissue-derived stromal cells,” International Journal of Cardiology, vol. 243, pp. 421–423, 2017. View at Publisher · View at Google Scholar
  98. L. Iop, A. Chiavegato, A. Callegari et al., “Different cardiovascular potential of adult- and fetal-type mesenchymal stem cells in a rat model of heart cryoinjury,” Cell Transplantation, vol. 17, pp. 679–694, 2008. View at Publisher · View at Google Scholar · View at Scopus
  99. M. Pozzobon, S. Bollini, L. Iop et al., “Human bone marrow-derived CD133+ cells delivered to a collagen patch on cryoinjured rat heart promote angiogenesis and arteriogenesis,” Cell Transplantation, vol. 19, pp. 1247–1260, 2010. View at Publisher · View at Google Scholar · View at Scopus
  100. V. Turinetto, E. Vitale, and C. Giachino, “Senescence in human mesenchymal stem cells: functional changes and implications in stem cell-based therapy,” International Journal of Molecular Sciences, vol. 17, p. 1164, 2016. View at Publisher · View at Google Scholar · View at Scopus
  101. M. Demaria, N. Ohtani, S. Youssef et al., “An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA,” Developmental Cell, vol. 31, pp. 722–733, 2014. View at Publisher · View at Google Scholar · View at Scopus
  102. M. Takasugi, R. Okada, A. Takahashi, D. Virya Chen, S. Watanabe, and E. Hara, “Small extracellular vesicles secreted from senescent cells promote cancer cell proliferation through EphA2,” Nature Communications, vol. 8, article 15729, 2017. View at Publisher · View at Google Scholar
  103. O. H. Jeon, C. Kim, R.-M. Laberge et al., “Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment,” Nature Medicine, vol. 23, pp. 775–781, 2017. View at Publisher · View at Google Scholar
  104. D. J. Baker, T. Wijshake, T. Tchkonia et al., “Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders,” Nature, vol. 479, pp. 232–236, 2011. View at Publisher · View at Google Scholar · View at Scopus
  105. W. Xue, L. Zender, C. Miething et al., “Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas,” Nature, vol. 445, p. 656, 2007. View at Publisher · View at Google Scholar · View at Scopus
  106. R. S. Petralia, M. P. Mattson, and P. J. Yao, “Aging and longevity in the simplest animals and the quest for immortality,” Ageing Research Reviews, vol. 16, pp. 66–82, 2014. View at Publisher · View at Google Scholar · View at Scopus
  107. C. E. Finch, “Longevity, senescence and the genome,” in Negligible Senescence, University of Chicago Press, Chicago, IL, USA, 1994. View at Google Scholar
  108. A. D. N. J. de Grey, B. N. Ames, J. K. Andersen et al., “Time to talk SENS: critiquing the immutability of human aging,” Annals of the New York Academy of Sciences, vol. 959, pp. 452–465, 2002. View at Publisher · View at Google Scholar
  109. L. Samaraweera, A. Adomako, A. Rodriguez-Gabin, and H. M. Mcdaid, “A novel indication for panobinostat as a senolytic drug in NSCLC and HNSCC,” Scientific Reports, vol. 7, p. 1900, 2017. View at Publisher · View at Google Scholar
  110. C. M. Roos, B. Zhang, A. K. Palmer et al., “Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice,” Aging Cell, vol. 15, pp. 973–977, 2016. View at Publisher · View at Google Scholar · View at Scopus
  111. S. L. Khaw, D. Mérino, M. A. Anderson et al., “Both leukaemic and normal peripheral B lymphoid cells are highly sensitive to the selective pharmacological inhibition of prosurvival Bcl-2 with ABT-199,” Leukemia, vol. 28, pp. 1207–1215, 2014. View at Publisher · View at Google Scholar · View at Scopus
  112. M. Jung, Y. Ma, R. P. Iyer et al., “IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation,” Basic Research in Cardiology, vol. 112, p. 33, 2017. View at Publisher · View at Google Scholar
  113. A. De Angelis, E. Piegari, D. Cappetta et al., “SIRT1 activation rescues doxorubicin-induced loss of functional competence of human cardiac progenitor cells,” International Journal of Cardiology, vol. 189, pp. 30–44, 2015. View at Publisher · View at Google Scholar · View at Scopus
  114. F. S. Loffredo, M. L. Steinhauser, S. M. Jay et al., “Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy,” Cell, vol. 153, pp. 828–839, 2013. View at Publisher · View at Google Scholar · View at Scopus
  115. F. Villa, A. Carrizzo, C. C. Spinelli et al., “Genetic analysis reveals a longevity-associated protein modulating endothelial function and angiogenesisnovelty and significance,” Circulation Research, vol. 117, pp. 333–345, 2015. View at Publisher · View at Google Scholar · View at Scopus
  116. F. Villa, A. Malovini, A. Carrizzo et al., “Serum BPIFB4 levels classify health status in long-living individuals,” Immunity & Ageing, vol. 12, p. 27, 2015. View at Publisher · View at Google Scholar · View at Scopus
  117. G. Spinetti, E. Sangalli, C. Specchia et al., “The expression of the BPIFB4 and CXCR4 associates with sustained health in long-living individuals from Cilento-Italy,” Aging, vol. 9, pp. 370–380, 2017. View at Publisher · View at Google Scholar
  118. C. C. Spinelli, A. Carrizzo, A. Ferrario et al., “LAV-BPIFB4 isoform modulates eNOS signalling through Ca2+/PKC-alpha-dependent mechanism,” Cardiovascular Research, vol. 113, pp. 795–804, 2017. View at Publisher · View at Google Scholar
  119. A. A. Puca, G. Spinetti, R. Vono, C. Vecchione, and P. Madeddu, “The genetics of exceptional longevity identifies new druggable targets for vascular protection and repair,” Pharmacological Research, vol. 114, pp. 169–174, 2016. View at Publisher · View at Google Scholar · View at Scopus
  120. B. Wang, W. Y.-W. Lee, B. Huang et al., “Secretome of human fetal mesenchymal stem cell ameliorates replicative senescence,” Stem Cells and Development, vol. 25, pp. 1755–1766, 2016. View at Publisher · View at Google Scholar · View at Scopus
  121. A. R. Williams, K. E. Hatzistergos, B. Addicott et al., “Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction,” Circulation, vol. 127, pp. 213–223, 2013. View at Publisher · View at Google Scholar · View at Scopus
  122. I. Chimenti, F. Pagano, E. Cavarretta et al., “Β-blockers treatment of cardiac surgery patients enhances isolation and improves phenotype of cardiosphere-derived cells,” Scientific Reports, vol. 6, p. 36774, 2016. View at Publisher · View at Google Scholar · View at Scopus
  123. R. R. Makkar, R. R. Smith, K. Cheng et al., “Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial,” The Lancet, vol. 379, pp. 895–904, 2012. View at Publisher · View at Google Scholar · View at Scopus
  124. K. Malliaras, R. R. Makkar, R. R. Smith et al., “Intracoronary cardiosphere-derived cells after myocardial infarction,” Journal of the American College of Cardiology, vol. 63, pp. 110–122, 2014. View at Publisher · View at Google Scholar · View at Scopus
  125. E. Avolio, G. Gianfranceschi, D. Cesselli et al., “Ex vivo molecular rejuvenation improves the therapeutic activity of senescent human cardiac stem cells in a mouse model of myocardial infarction,” Stem Cells, vol. 32, pp. 2373–2385, 2014. View at Publisher · View at Google Scholar · View at Scopus
  126. S. Mohsin, M. Khan, J. Nguyen et al., “Rejuvenation of human cardiac progenitor cells with Pim-1 kinase,” Circulation Research, vol. 113, pp. 1169–1179, 2013. View at Publisher · View at Google Scholar · View at Scopus
  127. M. Nakagawa, M. Koyanagi, K. Tanabe et al., “Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts,” Nature Biotechnology, vol. 26, pp. 101–106, 2007. View at Publisher · View at Google Scholar · View at Scopus
  128. K. Takahashi, K. Okita, M. Nakagawa, and S. Yamanaka, “Induction of pluripotent stem cells from fibroblast cultures,” Nature Protocols, vol. 2, pp. 3081–3089, 2007. View at Publisher · View at Google Scholar · View at Scopus
  129. L. Lapasset, O. Milhavet, A. Prieur et al., “Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state,” Genes & Development, vol. 25, pp. 2248–2253, 2011. View at Publisher · View at Google Scholar · View at Scopus
  130. Y. Hayashi, E. C. Hsiao, S. Sami et al., “BMP-SMAD-ID promotes reprogramming to pluripotency by inhibiting p16/INK4A-dependent senescence,” Proceedings of the National Academy of Sciences of the United States of America, vol. 113, pp. 13057–13062, 2016. View at Publisher · View at Google Scholar · View at Scopus
  131. L. Zhou, X. Chen, T. Liu et al., “SIRT1-dependent anti-senescence effects of cell-deposited matrix on human umbilical cord mesenchymal stem cells,” Journal of Tissue Engineering and Regenerative Medicine, 2017. View at Publisher · View at Google Scholar
  132. Y. Li, H. Asfour, and N. Bursac, “Age-dependent functional crosstalk between cardiac fibroblasts and cardiomyocytes in a 3D engineered cardiac tissue,” Acta Biomaterialia, vol. 55, pp. 120–130, 2017. View at Publisher · View at Google Scholar